230 related articles for article (PubMed ID: 25510661)
21. Amyotrophic lateral sclerosis and skeletal muscle: an update.
Pansarasa O; Rossi D; Berardinelli A; Cereda C
Mol Neurobiol; 2014 Apr; 49(2):984-90. PubMed ID: 24198230
[TBL] [Abstract][Full Text] [Related]
22. Abnormalities of satellite cells function in amyotrophic lateral sclerosis.
Pradat PF; Barani A; Wanschitz J; Dubourg O; Lombès A; Bigot A; Mouly V; Bruneteau G; Salachas F; Lenglet T; Meininger V; Butler-Browne G
Amyotroph Lateral Scler; 2011 Jul; 12(4):264-71. PubMed ID: 21473708
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial changes in skeletal muscle in amyotrophic lateral sclerosis and other neurogenic atrophies.
Krasnianski A; Deschauer M; Neudecker S; Gellerich FN; Müller T; Schoser BG; Krasnianski M; Zierz S
Brain; 2005 Aug; 128(Pt 8):1870-6. PubMed ID: 15901649
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial dysfunction in blood cells from amyotrophic lateral sclerosis patients.
Ehinger JK; Morota S; Hansson MJ; Paul G; Elmér E
J Neurol; 2015 Jun; 262(6):1493-503. PubMed ID: 25893255
[TBL] [Abstract][Full Text] [Related]
25. Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity.
Bendotti C; Calvaresi N; Chiveri L; Prelle A; Moggio M; Braga M; Silani V; De Biasi S
J Neurol Sci; 2001 Oct; 191(1-2):25-33. PubMed ID: 11676989
[TBL] [Abstract][Full Text] [Related]
26. A robust TDP-43 knock-in mouse model of ALS.
Huang SL; Wu LS; Lee M; Chang CW; Cheng WC; Fang YS; Chen YR; Cheng PL; Shen CJ
Acta Neuropathol Commun; 2020 Jan; 8(1):3. PubMed ID: 31964415
[TBL] [Abstract][Full Text] [Related]
27. Alterations in muscle proteome of patients diagnosed with amyotrophic lateral sclerosis.
Elf K; Shevchenko G; Nygren I; Larsson L; Bergquist J; Askmark H; Artemenko K
J Proteomics; 2014 Aug; 108():55-64. PubMed ID: 24846852
[TBL] [Abstract][Full Text] [Related]
28. Differential motor neuron involvement in progressive muscular atrophy: a comparative study with amyotrophic lateral sclerosis.
Riku Y; Atsuta N; Yoshida M; Tatsumi S; Iwasaki Y; Mimuro M; Watanabe H; Ito M; Senda J; Nakamura R; Koike H; Sobue G
BMJ Open; 2014 May; 4(5):e005213. PubMed ID: 24833696
[TBL] [Abstract][Full Text] [Related]
29. TDP-43 in differential diagnosis of motor neuron disorders.
Dickson DW; Josephs KA; Amador-Ortiz C
Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
[TBL] [Abstract][Full Text] [Related]
30. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.
Al-Sarraj S; King A; Troakes C; Smith B; Maekawa S; Bodi I; Rogelj B; Al-Chalabi A; Hortobágyi T; Shaw CE
Acta Neuropathol; 2011 Dec; 122(6):691-702. PubMed ID: 22101323
[TBL] [Abstract][Full Text] [Related]
31. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
Yamashita T; Kwak S
Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
[TBL] [Abstract][Full Text] [Related]
32. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72.
Cooper-Knock J; Hewitt C; Highley JR; Brockington A; Milano A; Man S; Martindale J; Hartley J; Walsh T; Gelsthorpe C; Baxter L; Forster G; Fox M; Bury J; Mok K; McDermott CJ; Traynor BJ; Kirby J; Wharton SB; Ince PG; Hardy J; Shaw PJ
Brain; 2012 Mar; 135(Pt 3):751-64. PubMed ID: 22366792
[TBL] [Abstract][Full Text] [Related]
33. An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline.
Troakes C; Maekawa S; Wijesekera L; Rogelj B; Siklós L; Bell C; Smith B; Newhouse S; Vance C; Johnson L; Hortobágyi T; Shatunov A; Al-Chalabi A; Leigh N; Shaw CE; King A; Al-Sarraj S
Neuropathology; 2012 Oct; 32(5):505-14. PubMed ID: 22181065
[TBL] [Abstract][Full Text] [Related]
34. Measures of bulbar and spinal motor function, muscle innervation, and mitochondrial function in ALS rats.
Smittkamp SE; Spalding HN; Brown JW; Gupte AA; Chen J; Nishimune H; Geiger PC; Stanford JA
Behav Brain Res; 2010 Jul; 211(1):48-57. PubMed ID: 20211206
[TBL] [Abstract][Full Text] [Related]
35. Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism.
Keller BA; Volkening K; Droppelmann CA; Ang LC; Rademakers R; Strong MJ
Acta Neuropathol; 2012 Nov; 124(5):733-47. PubMed ID: 22941224
[TBL] [Abstract][Full Text] [Related]
36. Amyotrophic lateral sclerosis.
Wijesekera LC; Leigh PN
Orphanet J Rare Dis; 2009 Feb; 4():3. PubMed ID: 19192301
[TBL] [Abstract][Full Text] [Related]
37. Defective mitochondrial dynamics is an early event in skeletal muscle of an amyotrophic lateral sclerosis mouse model.
Luo G; Yi J; Ma C; Xiao Y; Yi F; Yu T; Zhou J
PLoS One; 2013; 8(12):e82112. PubMed ID: 24324755
[TBL] [Abstract][Full Text] [Related]
38. An autopsy case of early-stage amyotrophic lateral sclerosis with TDP-43 immunoreactive neuronal, but not glial, inclusions.
Kon T; Mori F; Oyama Y; Tanji K; Kimura T; Takahashi S; Wakabayashi K
Neuropathology; 2019 Jun; 39(3):224-230. PubMed ID: 31020724
[TBL] [Abstract][Full Text] [Related]
39. Ultrastructural changes of mitochondria in the skeletal muscle of patients with amyotrophic lateral sclerosis.
Chung MJ; Suh YL
Ultrastruct Pathol; 2002; 26(1):3-7. PubMed ID: 12028652
[TBL] [Abstract][Full Text] [Related]
40. Activities of mitochondrial complexes correlate with nNOS amount in muscle from ALS patients.
Sorarù G; Vergani L; Fedrizzi L; D'Ascenzo C; Polo A; Bernazzi B; Angelini C
Neuropathol Appl Neurobiol; 2007 Apr; 33(2):204-11. PubMed ID: 17359361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]